Literature DB >> 10318937

Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity.

O Mandelboim1, P Malik, D M Davis, C H Jo, J E Boyson, J L Strominger.   

Abstract

In addition to their role in peptide antigen presentation, class I MHC proteins also play a critical role in inhibiting natural killer (NK) cytotoxicity through interaction with NK inhibitory receptors. Thus, NK cells are cytotoxic to virus-infected and tumor cells that have lost class I MHC protein expression. However, the nature of the receptors involved in the triggering of lysis of target cells is poorly understood. CD16 (Fcgamma receptor III) has been described as a receptor expressed on NK cells that facilitates antibody-dependent cellular cytotoxicity (ADCC) by binding to the Fc portion of various antibodies. However, we show here that CD16 has a broader function and is directly involved in the lysis of some virus-infected cells and tumor cells, independent of antibody binding. The presence of a putative CD16 ligand on appropriate target cells has also been demonstrated by the use of a CD16-Ig fusion protein.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10318937      PMCID: PMC21913          DOI: 10.1073/pnas.96.10.5640

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C.

Authors:  V M Braud; D S Allan; C A O'Callaghan; K Söderström; A D'Andrea; G S Ogg; S Lazetic; N T Young; J I Bell; J H Phillips; L L Lanier; A J McMichael
Journal:  Nature       Date:  1998-02-19       Impact factor: 49.962

2.  HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A.

Authors:  N Lee; M Llano; M Carretero; A Ishitani; F Navarro; M López-Botet; D E Geraghty
Journal:  Proc Natl Acad Sci U S A       Date:  1998-04-28       Impact factor: 11.205

3.  A new mechanism of NK cell cytotoxicity activation: the CD40-CD40 ligand interaction.

Authors:  E Carbone; G Ruggiero; G Terrazzano; C Palomba; C Manzo; S Fontana; H Spits; K Kärre; S Zappacosta
Journal:  J Exp Med       Date:  1997-06-16       Impact factor: 14.307

4.  Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1.

Authors:  B Perussia; S Starr; S Abraham; V Fanning; G Trinchieri
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

5.  Human neutrophil Fc gamma receptor distribution and structure.

Authors:  H B Fleit; S D Wright; J C Unkeless
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

6.  Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity.

Authors:  A Pessino; S Sivori; C Bottino; A Malaspina; L Morelli; L Moretta; R Biassoni; A Moretta
Journal:  J Exp Med       Date:  1998-09-07       Impact factor: 14.307

7.  Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis.

Authors:  F Borrego; M Ulbrecht; E H Weiss; J E Coligan; A G Brooks
Journal:  J Exp Med       Date:  1998-03-02       Impact factor: 14.307

8.  NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily.

Authors:  C Cantoni; C Bottino; M Vitale; A Pessino; R Augugliaro; A Malaspina; S Parolini; L Moretta; A Moretta; R Biassoni
Journal:  J Exp Med       Date:  1999-03-01       Impact factor: 14.307

9.  Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules.

Authors:  O Mandelboim; H T Reyburn; M Valés-Gómez; L Pazmany; M Colonna; G Borsellino; J L Strominger
Journal:  J Exp Med       Date:  1996-09-01       Impact factor: 14.307

10.  NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis.

Authors:  M Vitale; C Bottino; S Sivori; L Sanseverino; R Castriconi; E Marcenaro; R Augugliaro; L Moretta; A Moretta
Journal:  J Exp Med       Date:  1998-06-15       Impact factor: 14.307

View more
  83 in total

1.  HLA-Cw7 zygosity affects the size of a subset of CD158b+ natural killer cells.

Authors:  Zaheed Husain; Edward Levitan; Charles E Larsen; Nadeem M Mirza; Souhad Younes; Edmond J Yunis; Chester A Alper; Devendra P Dubey
Journal:  J Clin Immunol       Date:  2002-01       Impact factor: 8.317

2.  Effects of DDT and triclosan on tumor-cell binding capacity and cell-surface protein expression of human natural killer cells.

Authors:  Tasia Hurd-Brown; Felicia Udoji; Tamara Martin; Margaret M Whalen
Journal:  J Appl Toxicol       Date:  2012-06-21       Impact factor: 3.446

3.  Opposite effects of serotonin and interferon-alpha on the membrane potential and function of human natural killer cells.

Authors:  Tibor Oláh; Imre Ocsovszki; Yvette Mándi; Rozália Pusztai; Márta Bakay; Elisabeth Balint
Journal:  In Vitro Cell Dev Biol Anim       Date:  2005 May-Jun       Impact factor: 2.416

4.  Influenza virus infection augments NK cell inhibition through reorganization of major histocompatibility complex class I proteins.

Authors:  Hagit Achdout; Irit Manaster; Ofer Mandelboim
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

5.  Distribution of several activating and inhibitory receptors on CD3-CD16+ NK cells and their correlation with NK cell function in healthy individuals.

Authors:  Gordana Konjević; Katarina Mirjacić Martinović; Ana Vuletić; Vladimir Jurisić; Ivan Spuzić
Journal:  J Membr Biol       Date:  2009-08-27       Impact factor: 1.843

6.  Tetrabromobisphenol A decreases cell-surface proteins involved in human natural killer (NK) cell-dependent target cell lysis.

Authors:  Tasia Hurd; Margaret M Whalen
Journal:  J Immunotoxicol       Date:  2011-05-31       Impact factor: 3.000

7.  Changes in natural killer cell subsets in pediatric liver transplant recipients.

Authors:  Betty Pham; Karine Piard-Ruster; Richard Silva; Amy Gallo; Carlos O Esquivel; Olivia M Martinez; Sheri M Krams
Journal:  Pediatr Transplant       Date:  2012-03

8.  NKp46 Recognizes the Sigma1 Protein of Reovirus: Implications for Reovirus-Based Cancer Therapy.

Authors:  Yotam Bar-On; Yoav Charpak-Amikam; Ariella Glasner; Batya Isaacson; Alexandra Duev-Cohen; Pinchas Tsukerman; Alexander Varvak; Michal Mandelboim; Ofer Mandelboim
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

9.  Hexabromocyclododecane decreases tumor-cell-binding capacity and cell-surface protein expression of human natural killer cells.

Authors:  Natasha C Hinkson; Margaret M Whalen
Journal:  J Appl Toxicol       Date:  2010-05       Impact factor: 3.446

10.  Natural killer lysis receptor (NKLR)/NKLR-ligand matching as a novel approach for enhancing anti-tumor activity of allogeneic NK cells.

Authors:  Gal Markel; Rachel Seidman; Michal J Besser; Naama Zabari; Rona Ortenberg; Ronnie Shapira; Avraham J Treves; Ron Loewenthal; Arie Orenstein; Arnon Nagler; Jacob Schachter
Journal:  PLoS One       Date:  2009-05-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.